Skip to main content

Carbidopa / Levodopa News

Subcutaneous Infusion of Levodopa-Carbidopa Beneficial for Parkinson Disease

THURSDAY, April 11, 2024 – Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a...

FDA Approves Duopa (carbidopa and levodopa) Enteral Suspension for Parkinson's Disease

NORTH CHICAGO, Ill., Jan. 12, 2015 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved AbbVie's (NYSE: ABBV) Duopa (carbidopa and levodopa) enteral suspension for the treatment...

Impax Pharmaceuticals Announce FDA Approval of Rytary (carbidopa and levodopa) for Parkinson's Disease

HAYWARD, Calif., Jan. 8, 2015 /PRNewswire/ – Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that the U.S. Food and Drug Administration (FDA) approved...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Parkinson's Disease, Restless Legs Syndrome

Carbidopa / Levodopa patient information at Drugs.com